×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学... [164]
山东大学 [96]
西安交通大学 [58]
上海药物研究所 [58]
四川大学 [58]
武汉大学 [55]
更多...
内容类型
期刊论文 [1062]
学位论文 [16]
会议论文 [9]
专利 [3]
发表日期
2021 [12]
2020 [11]
2019 [118]
2018 [136]
2017 [109]
2016 [114]
更多...
学科主题
Cell Biol... [18]
Oncology [18]
Biochemis... [16]
Biochemis... [13]
Genetics &... [8]
Science & ... [4]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共1090条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
JC-010a, a novel selective SHP2 allosteric inhibitor, overcomes RTK/non-RTK-mediated drug resistance in multiple oncogene-addicted cancers
期刊论文
CANCER LETTERS, 2024, 卷号: 582, 页码: 15
作者:
Lu, Xuxiu
;
Yu, Rilei
;
Li, Zhen
;
Yang, Mengke
;
Dai, Jiajia
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2024/04/07
Acquired resistance
Cancer
NSCLC
JC-010a
SHP2
Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract
期刊论文
CANCER COMMUNICATIONS, 2022
作者:
Wu, Huanwen
;
Yu, Zicheng
;
Liu, Yueping
;
Guo, Lei
;
Teng, Lianghong
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2022/12/22
Neuroendocrine carcinomas
Gastrointestinal tract
Genomic characterization
Heterogeneity
Therapeutic implications
Targeting KRAS mutant cancers: from druggable therapy to drug resistance
期刊论文
MOLECULAR CANCER, 2022, 卷号: 21
作者:
Zhu, Chunxiao
;
Guan, Xiaoqing
;
Zhang, Xinuo
;
Luan, Xin
;
Song, Zhengbo
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2022/12/23
KRAS mutations
Druggable
Resistance
Combination therapy
The Role of Anti-EGFR Monoclonal Antibody in mCRC Maintenance Therapy
期刊论文
FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 卷号: 9
作者:
Yuan, Meiqin
;
Wang, Zeng
;
Lv, Wangxia
;
Pan, Hongming
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2022/05/16
mCRC
maintenance therapy
EGFR
monoclonal antibody
panitumumab
cetuximab
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers
期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:
Cao, Jiang-yan
;
Qi, Shuang
;
Wu, Hong
;
Wang, Ao-li
;
Liu, Qing-wang
收藏
  |  
浏览/下载:92/0
  |  
提交时间:2022/03/28
HER2
breast cancers
gastric cancers
irreversible inhibitor
drug resistance
DNA damage-induced translocation of mitochondrial factor HIGD1A into the nucleus regulates homologous recombination and radio/chemo-sensitivity
期刊论文
ONCOGENE, 2022
作者:
Chen, Bin
;
Xu, Feng
;
Gao, Yang
;
Hu, Guanshuo
;
Zhu, Kaili
收藏
  |  
浏览/下载:65/0
  |  
提交时间:2022/03/21
Silencing of the lncRNA H19 enhances sensitivity to X-ray and carbon-ions through the miR-130a-3p /WNK3 signaling axis in NSCLC cells
期刊论文
Cancer Cell International, 2021, 卷号: 21, 期号: 1, 页码: 12
作者:
Zhao,Xueshan
;
Jin,Xiaodong
;
Zhang,Qiuning
;
Liu,Ruifeng
;
Luo,Hongtao
收藏
  |  
浏览/下载:222/0
  |  
提交时间:2021/12/13
LncRNA H19
MiR-130a-3p
WNK3
Non-small-cell lung cancer
Radiotherapy
Inner nuclear membrane protein TMEM201 promotes breast cancer metastasis by positive regulating TGF beta signaling
期刊论文
ONCOGENE, 2021, 页码: 10
作者:
Kong, Ya
;
Zhang, Yutian
;
Wang, Hanlin
;
Kan, Weijuan
;
Guo, Haoran
收藏
  |  
浏览/下载:49/0
  |  
提交时间:2022/01/04
A validated HPLC-MS/MS method for determination of simmitecan and its metabolite chimmitecan in human plasma and its application to a pharmacokinetic study in Chinese patients with advanced solid tumor
期刊论文
JOURNAL OF SEPARATION SCIENCE, 2021, 页码: 8
作者:
Zhou, Jun
;
Zhan, Yan
;
Zhong, Dafang
;
Chen, Xiaoyan
;
Zhang, Yifan
收藏
  |  
浏览/下载:70/0
  |  
提交时间:2021/11/04
chimmitecan
mass spectrometry
pharmacokinetics
simmitecan
solid tumors
Pulmonary enteric adenocarcinoma
期刊论文
TRANSLATIONAL ONCOLOGY, 2021, 卷号: 14
作者:
Gong, Jiali
;
Fan, Ying
;
Lu, Hongyang
收藏
  |  
浏览/下载:53/0
  |  
提交时间:2021/11/01
PEAC
Immunohistochemistry
Mutation analysis
Diagnosis
Prognosis
©版权所有 ©2017 CSpace - Powered by
CSpace